首页> 外文期刊>International Journal of Technology and Globalisation >Biopharmaceuticals and firm organisation in Argentina: opportunities and challenges
【24h】

Biopharmaceuticals and firm organisation in Argentina: opportunities and challenges

机译:阿根廷的生物制药和公司组织:机遇与挑战

获取原文
获取原文并翻译 | 示例
       

摘要

In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms' forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties - be they technological, regulatory, or commercial - associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.
机译:在阿根廷,一些在人类健康领域运营的生物技术公司设法在早期进入了全球生物制药市场的生物仿制药市场。这些公司的组织形式及其与当地科学技术基础设施的衔接在不促进解决特定风险和不确定性的制度背景下(无论是技术,法规还是商业-与这些产品相关联。本文通过案例研究来考察选定公司的策略。它假定经济团体中的公司组织以及公共/私有网络中的清晰表达使本地公司能够成功克服外围国家的创新生物技术公司所面临的障碍,进而导致实现技术和财务优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号